Clinical Trial Update: A Pilot Trial of Twice-weekly Versus Thrice-weekly Hemodialysis in Patients With Incident End-stage Kidney Disease [Phase 3]

View source ↗

Summary

A Phase 3 pilot trial comparing twice-weekly versus thrice-weekly hemodialysis in incident end-stage kidney disease patients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Kidney Failure

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: End Stage Renal Failure on Dialysis | Phase 3 | Status: COMPLETED | Results posted: 2023-06-05